Resveratrol to be studied for Metabolic Syndrome (Prediabetes) Treatment
The American Diabetes Association has given $600,000 to the researchers at Albert Einstein College of Medicine of Yeshiva University to study the effects of the compound resveratrol.
The chemical compound resveratrol can be found naturally in grapes and red wines. The research is focused on the effects of the compound in people who have metabolic syndrome also know as prediabetes the condition that comes before diabetes. The condition is also referred as impaired glucose intolerance (IGT) this happens when blood sugar levels are higher than normal but not high enough to be diagnosed as diabetes.
The study will be six-weeks long and a double blind study, meaning half the participants will be given the resveratrol and the other half a placebo. At this point in time, it is estimated that a person “would need to drink between 100-1000 bottles of wine per day to receive the levels shown to be therapeutic in mice.”
Results of Previous Resveratrol Studies
“In research in cells and animals, resveratrol has been shown to prolong lifespan, prevent cancer and heart disease, and normalize glucose metabolism. Although use of this agent shows great promise in the treatment and/or prevention of diabetes, there have been no rigorously controlled, peer-reviewed clinical studies in humans.”